NSEDisclosure under SEBI Takeover Regulations24 Jun 2026 · 24 Jun 2026, 11:32 am

Disclosure under SEBI Takeover Regulations

Tatva Chintan Pharma Chem Limited · TATVA

✦ AI SummaryRegulatory

Tatva Chintan Pharma Chem Limited has submitted a disclosure under SEBI Takeover Regulations, as per Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Tatva Chintan Pharma Chem Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.